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Abstract 
Gastrointestinal microbiota and immune cells interact closely and display 
regional specificity, but little is known about how these communities differ 
with location. Here, we simultaneously assess microbiota and single immune 
cells across the healthy, adult human colon, with paired characterization of 
immune cells in the mesenteric lymph nodes, to delineate colonic immune 
niches at steady-state. We describe distinct T helper cell activation and 
migration profiles along the colon and characterize the transcriptional 
adaptation trajectory of T regulatory cells between lymphoid tissue and colon. 
Finally, we show increasing B cell accumulation, clonal expansion and 
mutational frequency from cecum to sigmoid colon, and link this to the 
increasing number of reactive bacterial species.  
  
The colon, as a barrier tissue, represents a unique immune environment where 
immune cells display tolerance towards a diverse community of microbes - 
collectively known as the microbiome. The microbiome is critical for many aspects of 
health and an imbalance of commensals and pathogenic microbes is linked with 
many disease states 1. Thus, understanding what constitutes a healthy, homeostatic 
relationship between host immune cells and the microbiome of the human colon is of 
critical importance.  
 
The composition of the microbiota at any location in the intestines is determined by 
the availability of nutrients and oxygen, the transit rate of luminal content and 
compartmentalized host immune activity, and as such, is spatially distinct 2. Regional 
differences are most evident when comparing the small intestine and distal colon in 
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humans or other mammals 2. Within the colon, increasing bacterial diversity from 
proximal (including the cecum, ascending and transverse colon) to distal regions 
(comprising the descending and sigmoid colon connecting to the rectum) has been 
reported 3.   
 
The intestinal immune system has a symbiotic relationship with the microbiome and 
is central to the maintenance of epithelial barrier integrity. The lamina propria and 
associated lymphoid tissues contain one of the largest and most diverse 
communities of immune cells - including both lymphocytes and myeloid cells 4. There 
is marked regional variation in immune cells along the gastrointestinal tract, with T 
helper (TH) 17 cells decreasing in number from duodenum to colon, and T regulatory 
(Treg) cell numbers being highest in the colon 5. Immune cells can respond to 
environmental cues including the microbiota. Mouse studies have demonstrated that 
specific bacterial species can fine-tune intestinal immune responses, including TH17 
6,7, Treg 8, or TH1 9,10 and B cell activation 11. However, the extent to which there is 
regional variation in the mucosal microbiome within an individual, and how this might 
influence local immune cell niches along the colon, has not been investigated to 
date. 
 
Here, we catalogued the mucosal microbiome in different regions of the human 
colon, a gastrointestinal organ with the most diverse and dense microbiome content 
and region-restricted disease states 2. In parallel, we applied single-cell RNA-seq 
(scRNA-seq) to make a census of steady-state immune cell populations in the 
adjacent tissue and in draining mesenteric lymph nodes (mLN), available at 
www.gutcellatlas.org. We demonstrate previously unappreciated changes in the 
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proportions and activation status of T and B cells in distinct regions of the healthy 
human colon from proximal to distal, and relate these differences to the changing 
microbiota. 
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Results 
Microbiome composition differs along distinct colon regions  
To create a map of bacterial composition at the mucosal surface of the colon, we 
performed 16S ribosomal RNA (16S rRNA) sequencing of swabs from the mucosa 
surface of the cecum, transverse colon and sigmoid colon of twelve disease-free 
Caucasian deceased transplant donors (Methods, Figure 1a and Supplementary 
Table 1). The major gut phyla - Bacteroidetes, Firmicutes, Proteobacteria and 
Actinobacteria, were present throughout the gut of each donor (Figure 1b and 
Supplementary Table 2). While diversity of operational taxonomic units (OTUs) was 
consistent across the colon, and considerable variability existed between donor as 
previously reported 12 (Supplementary Figure 1a), we did observe changes in the 
composition of the microbiome. Most notably at the level of phyla, Bacteroidetes was 
more prevalent in sigmoid colon (Figure 1c and Supplementary Figure 1b). This was 
mostly attributable to an increase in Bacteroides, which dominates the colonic 
microbiome of individuals on high protein and fat diets typical in Western countries 13 
(Figure 1c and Supplementary Figure 1c). Additionally, Enterococcus was more 
prevalent in the proximal colon, and Coprobacillus and Escherichia/Shigella were 
more abundant in the distal colon, although these proportions varied considerably 
between donors (Figure 1b,c and Supplementary Figure 1c).  
 
Past studies characterizing the colonic microbiome typically rely on stool samples, 
which do not accurately recapitulate the composition of bacteria at the mucosal 
surface 14. Our catalog of mucosal bacteria throughout the colon demonstrates 
heterogeneity in the microbiome at the mucosal surface from proximal to distal colon, 
and reveals specific genera with preference for colonizing certain colon regions.  
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Immune cell heterogeneity in steady-state colon 
Next, we sought to determine whether the heterogeneity we observed in the colonic 
microbiome was accompanied by differences in the adjacent host immune cells. To 
this end, we generated high-quality transcriptional data from over 41,000 single 
immune cells from the mesenteric lymph nodes (mLN) and lamina propria of cecum, 
transverse colon and sigmoid colon (Figure 1a). We acquired tissue biopsies from 
five deceased transplant donors (Methods and Supplementary Table 1). Samples 
were dissociated to release cells from the mLN and lamina propria of colonic tissue. 
Immune cells were enriched either by flow-sorting of CD4+ T cells (live 
CD45+CD3+CD4+) and other immune cells (live CD45+CD3–CD4–), or by CD45+ 
magnetic bead selection or Ficoll gradient (Methods and Supplementary Figure 2a). 
Each fraction was then subjected to scRNA-seq (Figure 1a). Despite the enrichment 
for immune cells, we captured epithelial cells and fibroblasts and these were 
computationally removed from further analysis (Methods). 
 
Pooled analysis and visualization with Uniform Manifold Approximation and 
Projection (UMAP) of all four tissues from all donors revealed distinct clusters in the 
lymphoid and colonic tissues (Figure 2a and Supplementary Figure 2b). We 
identified 25 cell types and states in the intestinal lamina propria and mLN (Figure 
2a, Supplementary Table 3 and Supplementary Table 4), consistent with the immune 
populations described in recent reports 15. Among these were follicular and memory 
B cells, IgA+ and IgG+ plasma cells, effector and memory CD4+ T cells, T regulatory 
(Treg) cells, CD8+ T cells, γδ T cells, innate lymphoid cells (ILCs), natural killer (NK) 
cells, mast cells and myeloid cells (Figure 2a). Sub-clustering of myeloid cells 
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showed two distinct populations of conventional dendritic cells: cDC1 expressing 
XCR1, CADM1, CLEC9A, BATF3 and IDO1, and cDC2 expressing CLEC10A and 
CD86 (Figure 2a,b). In addition, we identified monocytes expressing CD14 and 
CD68, macrophages expressing FCGR3A (gene encoding CD16), LYVE1+ 
macrophages 16 and plasmacytoid DCs (pDCs) expressing IRF4 and SELL. B cells, 
DCs and γδ T cells had MKI67+ cycling populations suggesting higher rates of 
proliferation compared to other colonic immune cell populations (Figure 2a,b). 
 
To determine how immune cells differ along the colon from proximal to distal regions, 
we investigated the relative proportions of cell types within mLN and colon regions 
(Figure 2c,d). Since CD4+ T cells and all other immune cells were sorted separately 
during initial tissue processing, our analyses here were also kept separate. As noted 
from our visual inspection of the UMAP plot (Figure 2a), there were major differences 
in the cell types present between mLN and the colon. In particular, there were 
marked differences in the activation and memory status of T and B cells between the 
colon and lymph nodes, suggesting that these cell types are molded by their 
environment (Figure 2c,d). In the mLN, CD4+ T cells were typically CXCR5+, ICOShi 
follicular helper cells, and SELL+ (encodes CD62L), CCR7+ central memory cells 
(Figure 2b,c). In contrast, colonic CD4+ T cells had a more effector phenotype, 
expressing high levels of the tissue residency marker CD69 17, falling into the TH17 
(CCR6+, IL22+, CCL20+) or TH1 (CXCR3+, IFNG+) subtypes. There was an inverted 
gradient in the relative proportion of TH17 and TH1 cells, with the cecum dominated 
by TH17 cells that reduced in frequency in the transverse colon, and still further in the 
sigmoid colon, and TH1 cells following the opposite trend, being more abundant in 
the sigmoid colon (Figure 2c). This distinct distribution of colonic TH1 and TH17 cells 
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is concordant with spatial variation of the microbiome, hinting at a relationship 
between the two populations.  
 
B cells in the mLN were predominantly CD19+, MS4A1+ (encodes CD20), CD40+, 
TNFRSF13B+ (encodes TACI), CD38– memory or CXCR5+, TCL1A+, FCER2+ 
(encodes CD23) follicular B cells (Figure 2b,d). In contrast, in the three regions of the 
colon, the main population of B cells were SDC1+ (encodes CD138), CD38+, plasma 
cells. Plasma cells were enriched in the sigmoid colon relative to both the cecum and 
transverse colon, whereas the proportion of memory B cells was lower in the sigmoid 
colon (Figure 2d). This suggests that conditions in the sigmoid colon may favor the 
generation of plasma cells rather than memory B cells from germinal center 
responses in this region, or that the tissue contains more plasma cell niches. 
 
T helper cells disseminate through the colon and adopt region-specific 
transcriptional profiles 
We next investigated CD4+ T effector cells across the colon. These were annotated 
above based on expression of functional markers (IL17A, IL22 and CCL20 versus 
IFNG and CXCR3) (Supplementary Figure 3a) rather than transcriptional regulators 
(RORC and TBX21) that are lowly expressed. Correlation analysis of TH1 and TH17 
cells between different colon tissues revealed high transcriptional similarity between 
these effector cell subtypes (Figure 3a), with mLN versus peripheral tissue signature 
accounting for the greatest amount of variability (Spearman’s corr = 0.88). Within the 
effector T cells of the colon, transverse colon and cecum cells cluster by T helper 
subtype. TH1 and TH17 cells of the sigmoid colon did not cluster with their respective 
effector subtypes from other regions. Differential gene expression analysis between 
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the effector cells in the sigmoid colon versus those in cecum and transverse colon 
revealed higher expression of activation-related molecules including TANK (TRAF 
family member associated NF-kB activator) (adjusted P < 10–10), CD83 (adjusted P < 
10–10) and PIM3 (adjusted P < 10–8) (Figure 3b). Expression of CCL20, encoding the 
ligand for CCR6 that is expressed by epithelial and myeloid cells more highly in small 
intestines than colon 18, was also slightly increased by T helper cells of the proximal 
colon (Figure 3b). Although this is likely due to higher abundance of CCL20+ TH17 
cells at this site (Figure 2c and Supplementary Figure 3a). Conversely, sigmoid colon 
effector T cells showed higher expression of KLF2 (adjusted P < 10–14) (Figure 3b) 
that encodes a transcriptional factor that transactivates the promoter for 
Sphingosine-1-phosphate receptor 1 (S1PR1) and is critical for T cell recirculation 
through peripheral lymphoid tissue 19, LMNA (adjusted P < 10–47) that encodes a 
molecule that is reported to promote TH1 differentiation 20 and EEF1G (adjusted P < 
10–13) that encodes a driver of protein synthesis.  
 
Next, we looked into the clonal relationships between T helper cells. We performed 
plate-based Smartseq2 on TCRα/β+ flow-sorted cells from colon regions and mLN of 
a sixth donor to capture paired gene expression and TCR sequences from individual 
T cells. Clonal groups were shared between TH1 and TH17 subtypes, supporting the 
notion that effector fate of CD4+ T cells is determined after their initial activation 21. 
Additionally, clonal expansion was observed by TH1 cells of the sigmoid colon 
(Figure 3c), in line with greater abundance in this tissue. Likewise, clonal expansion 
of TH17 cells was greatest in the cecum matching accumulation seen with the 
droplet-based scRNA-seq analysis. Several TH1 and TH17 clonal sisters were shared 
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between clonal sites (Figure 3c), evidence that T helper clones disseminate to 
distant regions of the colon.  
 
Together these data demonstrate region-specific transcriptional differences relating 
to activation and tissue migration in TH1 and TH17 cells of the proximal and sigmoid 
colon. Identification of clonal sharing between these colon regions supports the idea 
that these observed transcriptional differences are due to cell-extrinsic rather than 
intrinsic factors.  
 
Activation trajectory of colonic CD4+ T regulatory cells 
Treg cells are known to play a role in balancing the immune activity of other CD4+ T 
cell subsets. Documented Treg cell activation by Clostridium spp.8 and previous 
descriptions of tissue-specific transcriptional profiles 22 inspired us to interrogate 
these cells in greater detail. Firstly, we noted that the relative proportion of Treg cells 
did not change significantly from proximal to distal colon (Figure 2c). We then 
investigated whether the transcriptional profiles of Treg cells from different 
compartments indicated distinct activation states or functionalities.  
 
As previously observed in the mouse 22, sub-clustering of Treg cells from the mLN 
revealed major populations of central Treg cells and effector Treg cells (Figure 4a). 
Central Treg cells were defined by highest expression of SELL, while effector Treg 
cells were characterized by genes associated with the TNFRSF-NF-κB pathway 
(TNFRSF9 and TNF) (Supplementary Figure 4a). In addition, we observed a 
population, previously termed non-lymphoid tissue-like Treg cells (NLT-like Treg). 
These have characteristics of non-lymphoid tissue Treg cells, including high 
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expression of FOXP3, PRDM1, RORA, IL2RG, IL2RA and CTLA4 (Figure 4a & 
Supplementary Figure 4a). A fourth population, termed Treg-like cells, lacked the 
conventional markers of Treg cells - FOXP3 and IL2RA - but clustered more closely 
with Treg cells than conventional T cells (Figure 4a and Supplementary Figure 4b). 
These expressed the highest levels of PDCD1 (gene encoding PD-1) among Treg cell 
populations and, uniquely for this cell type, the transmembrane protein-encoding 
gene MS4A6A (Supplementary Figure 4a). This population of Treg-like cells could 
represent a Treg population that transiently loses FOXP3 expression 23.  
 
In the colon, Treg cells clustered into three populations as previously described in 
mouse (Figure 4a) 22. KLRB1+ (also known as CD161) Treg cells were characterized 
by expression of LAG3, IL2RA, CTLA4, KLRB1, ICOS and FOXP3 (Supplementary 
Figure 4a) suggesting a robust regulatory function, analogous to CD161+ Treg cells 
described in human colon tissue 24. Non-lymphoid tissue Treg (NLT Treg) cells express 
IKZF2, GATA3 and DUSP4 (Supplementary Figure 4a) consistent with the profile of 
thymic-derived Treg cells 25. The third population exhibited a profile reminiscent of 
lymphoid tissue Treg cells with expression of SELL, CCR7, TCR7, CXCR5 and 
RGS2, and were termed Lymphoid Tissue-like Treg (LT-like Treg) cells 
(Supplementary Figure 4a). LT-like Treg cells are likely newly arrived in the colon 
tissue from mLN. A small number of Ki67+ Treg cells were also identified in the colon 
and mLN (Figure 4a and Supplementary Table 3). The proportions of these subsets 
varied by donor, but were mostly consistent between colon regions (Figure 4b). 
 
The presence of NLT-like Treg cells in the mLN and LT-like Treg cells in the colon, 
both with profiles suggesting migration, led us to recreate this migration pathway in 
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silico. We ordered all Treg cells along “pseudospace” using Monocle2. This gave rise 
to a smooth pseudospace trajectory from resting central Treg cells in the mLN to 
highly regulatory Treg cells in the colon (Figure 4c). As seen in the mouse 22, NLT-like 
Treg cells and LT-like Treg cells blended in the middle of the trajectory, in accordance 
with these cells representing transitioning and migratory populations between 
lymphoid and peripheral tissues. In order to understand which gene signatures drive 
the migration and tissue adaptation of Treg cells in human tissues, we determined the 
genes changing along the previously calculated pseudospace (Figure 4c). Genes 
expressed at the beginning of pseudospace included SELL, CCR7 and CXCR4, 
permitting entry into lymph nodes (Figure 4c). At the end of pseudospace, the most 
highly expressed genes were FOXP3, IL2RA, CTLA4, IL10 and LAG3. These genes 
encoding suppressive molecules were co-expressed with TNF receptor genes 
(TNFRSF4, TNFRSF14, TNFRSF18, TNFRSF1B) indicating a reliance on the 
TNFRSF-NF-κB axis. Genes encoding chemokine receptors, CXCR3, CXCR6, 
CCR6 and CCR4, were also expressed by Treg cells in the periphery, matching 
previous reports of TH1- and TH17-like Treg cells in the colon (Figure 4c)22.  
 
Together, these results highlight heterogeneity in Treg cell states in mLN and colon, 
and reveal a possible FOXP3-transiently absent population. We also infer a 
continuous activation trajectory of these Treg cell states between draining lymph 
nodes and colon, and highlight genes regulating Treg cell migration between tissues 
and their adoption of Th-like profiles.  
 
B cells display a proximal-to-distal colon activation gradient 
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Following from our observations in CD4+ T cells across the colon, we next focused 
on humoral responses by performing a more in-depth analysis of B cells in different 
colon regions. We compared transcriptional profiles of plasma cells between different 
colonic regions. This analysis revealed CCL3 and CCL4 as highly enriched in cecal 
plasma cells (log fold change of 0.61 and 0.70 and adjusted P <10–28 and <10–9 
respectively) (Figure 5a). These chemokine-encoding genes are expressed by B 
cells in response to BCR activation 26 and result in the migration of CCR5-expressing 
cells such as T cells and monocytes 27 to the tissue microenvironment. This suggests 
that BCR cross-linking and signaling may be more prominent in the proximal colon. 
Cecal plasma B cells were also enriched for CXCR4 (log fold change of 0.44, 
adjusted P < 10–10) (Figure 5a), which encodes a chemokine receptor highly 
expressed by germinal center (GC) B cells and important for the movement of 
plasmablasts to the GC-T zone interface post-GC responses 28.  
 
Among the genes more highly expressed by plasma cells in the sigmoid colon was 
CD27 (Figure 5a; log fold change of 0.24; adjusted P <10–40), encoding a member of 
the TNF receptor family that is expressed by memory B cells and even more highly 
by plasma cells 29. We confirmed differential expression of CD27 protein and 
additionally observed a proximal-to-distal gradient of increasing CD27 expression by 
plasma cells in the colon (Figure 5b). Targeted homing of B cells from their site of 
activation in lymphoid tissues to the colonic lamina propria relies on signaling 
through CCR10 and its cognate ligand, CCL28, and integrin α4β7 30. CCR10 (log fold 
change of 0.24; adjusted P < 10–16), ITGA4 (log fold change of 0.58; adjusted P < 
10–24) and ITGB4 (log fold change 0.57; adjusted P < 10–108) were also more highly 
expressed by sigmoid colon IgA+ plasma cells (Figure 5a). 
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To determine whether the B cell clonal repertoire changes across the colon, we took 
advantage of the paired single-cell VDJ-sequencing data available from two donors 
for which scRNA-seq libraries were generated using 10x Genomics 5’ chemistry. We 
confirmed the expression of IgM and IgD isotypes by follicular B cells, IgG1 and IgG2 
by IgG+ plasma cells, IgA1 and IgM expression by memory cells in the mLN and 
predominantly IgA2 expression by plasma cells of the colon (Figure 5c). The 
mutation frequency of the heavy chain variable region was greatest in the plasma 
cells followed by memory B cells, indicating more somatic hypermutation by these 
cell types compared to the naive follicular B cells (Figure 5d). Additionally, while 
mutational frequency was consistent across colon regions and mLN for memory and 
follicular B cells, it was significantly increased in IgA+ plasma cell of the sigmoid 
colon compared to the other colon regions (Figure 5e). IgG+ plasma cells also 
showed a trend towards increased mutational frequency in the sigmoid colon, 
however their numbers were limiting (Figure 5e).  
 
We then identified clonally-related B cells to explore clonal expansion dynamics of 
different cellular populations throughout the gut. Clonal expansion was evident in 
memory B cells, IgA+ plasma cells and IgG+ plasma cells (Figure 5f). While the 
relative abundance of clonal groups did not differ across the colon regions of 
memory B cells and IgG+ plasma cells, again this was greatest for IgA+ plasma cells 
in the sigmoid colon (Figure 5f). This was supported by bootstrapped VDJ sequence 
diversity analysis of clonally-related IgA+ plasma cells, which showed that the 
diversity of BCR sequences was consistent between donors and that there was a 
trend for decreased diversity (consistent with higher rates of clonal expansion) of 
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IgA+ plasma cells in the sigmoid colon (Supplementary Figure 5a,b). Although some 
clones were shared between B cell types (i.e. memory and IgA+ plasma), indicating 
that alternate B cell fates can derive from a single precursor cell, most expanded 
clones within the gut were of the same cell type (Supplementary Figure 5c). Finally, 
we found many examples of B cell clones shared between all three colonic regions, 
and to a lesser extent the mLN, for both donors (Figure 5g), indicating dissemination 
of B cells throughout the colon as previously reported 31. Our observation of B cell 
dissemination throughout the colon was replicated with bulk BCR sequencing from 
whole tissue (Figure 5h). Increased clonal variability of sigmoid colon B cells was 
reflected in a greater spread of BCR variable chains expressed compared with 
cecum and transverse colon (Supplementary Figure 5d), altogether suggesting a 
more active response in the distal versus proximal colon.  
 
These data indicate a highly activated state of plasma cells in the distal colon 
compared with proximal colon plasma cells, characterized by greater accumulation, 
somatic hypermutation, clonal expansion and stronger homing to the colon mucosa.  
 
IgA is responsive to a richer microbial community in the sigmoid colon 
Previous reports have shown that IgA is secreted by plasma cells in response to the 
presence of specific bacteria species, rather than as a general response to the 
microbiome 32. In light of this, we examined whether the increased plasma cell 
activation we observed in the sigmoid colon was linked to the differences in bacteria 
species. To this end, we assessed IgA-opsonization of bacteria from the donor 
microbiome samples (Figure 6a). A greater proportion of bacteria from the sigmoid 
colon was positive for IgA-binding compared with bacteria of the cecum and 
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transverse colon (Figure 6b). Furthermore, shotgun sequencing of IgA-opsonized 
bacteria revealed a richer community of species in the sigmoid colon (Figure 6c and 
Supplementary Table 5). Diversity of IgA-bound bacteria, which considers relative 
abundance of each species, was lower in the sigmoid colon compared to cecum 
(Figure 6d).  
 
These data suggest that, compared with the cecum, IgA+ plasma cells of the sigmoid 
colon respond to a rich and unevenly represented community of bacterial species, 
likely contributing to their increased activation status, strong homing to the colon and 
trend towards greater clonal diversity (Supplementary Figure 6).  
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Discussion 
In this study we performed the first simultaneous assessment of the colonic mucosal 
microbiome and immune cells in human donors at steady-state. This enabled us to 
compare lymphoid and peripheral tissue immunity and explore how immune cells 
and their neighboring microbiome change along the colon within the same 
individuals. In doing so, we highlight previously unappreciated regional differences in 
both cellular communities. Our unique annotated colon immune single-cell dataset is 
available at www.gutcellatlas.org, where users can visualize their genes of interest. 
 
We describe a shift in the balance of T helper subsets, with a predominance of TH17 
in the cecum and TH1 in the sigmoid colon. Decreasing abundance of TH17 cells has 
similarly been shown from proximal small intestine to colon of mice 5. Additionally, 
simultaneous increase of the genus Bacteroides and TH1 numbers in the sigmoid 
colon are in line with findings that polysaccharide from Bacteroides fragilis 
preferentially induces TH1 differentiation in the intestine of germ-free mice 9. An 
alternative or complementary explanation for skewed T helper proportions and 
variation in transcriptional profiles is offered in a study by Harbour et al., which 
demonstrated that TH17 cells can give rise to a IFNy+ ‘TH1-like’ cell in response to IL-
23 production by innate cells 33. These findings demonstrate the complexity of 
external signals shaping colonic Th responses leading to regional changes in their 
numbers and differentiation.  
 
In contrast to conventional T cells, Treg cells are evenly represented across the colon. 
Treg cell subpopulations within the mLN and colon tissue are analogous to those we 
have recently described in mouse 22. We also identify an additional population, 
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termed Treg-like cells, reminiscent of a CD25–FOXP3loPD1hi Treg population in the 
peripheral blood, although the latter was described to also express Ki67 34. This 
population could represent uncommitted Treg cells experiencing transient loss of 
FOXP3 while retaining regulatory potential 23 or permanent loss FOXP3 and 
adoption of a more pro-inflammatory phenotype after repeated stimulation 35. Our 
pseudospace analysis of Treg cells suggests a continuum of activation states from 
resting cells in the lymphoid tissue through to highly suppressive cells in the 
periphery. We identify genes underlying this transition including chemokine receptors 
that are strongly expressed on arrival in the intestine that enable interaction with, and 
suppression of, TH1 and TH17 cells 36. Similarly to mouse, pseudospace from 
lymphoid to peripheral tissue correlates with transcriptional markers of migratory 
potential and suppression of effector cells. 
 
We find that IgA+ plasma cells are more abundant and have greater expression of 
colon-specific migration markers (CCR10, ITGA4 and ITGB7) in the sigmoid colon 
compared to the proximal colon. This adds finer resolution to previous reports 
describing increasing abundance of IgA+ plasma cells from the small intestine to the 
colon 37. Our B cell repertoire analysis demonstrates extensive clonal expansion 
within each colon region and to a lesser extent between regions, arguing for colonic 
dissemination of B cells from the same precursor pool, followed by local expansion. 
Furthermore, more clonal sharing existed between regions of the colon than with 
mLN, consistent with recent work showing that while mLN clones can also be 
detected in blood, the intestines are host to a unique B cell clonal network 38. 
Sigmoid colon plasma cells, in particular, exhibit greater mutational abundance and 
clonal expansion. This is consistent with a trend towards reduced plasma cell clonal 
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diversity in the sigmoid colon. While this was not statistically significant, this may 
have been due to the relatively low number of VDJ sequences obtained from these 
samples, thus decreasing the power of this analysis. Previous work has shown the 
mutational frequency of B cells is consistently high between duodenum and colon 
and are primarily driven by dietary and microbiome antigens respectively 39. Thus, 
we suggest that enhanced plasma cell accumulation, mutation and expansion in the 
sigmoid colon is in response to continued stimulation from the local microbiome. This 
may happen through increased engagement of sigmoid colon plasma cells in T cell-
mediated germinal center reactions in gut-associated lymphoid structures or in T 
cell-independent somatic hypermutation in local isolated lymphoid follicles 40 followed 
by local expansion. Yet the exact mechanisms require further study.  
 
Finally, we show greater IgA binding to the microbiome in the sigmoid colon 
compared to proximal sites. One possible explanation for this observation is the 
accumulation of upstream secreted IgA and IgA-bound bacteria in the sigmoid colon. 
However, our simultaneous observation of enhanced plasma cell responses in the 
sigmoid colon suggests that IgA is locally produced as a result of immune poising. 
Possible scenarios contributing to a richer immune-reactive microbiome in the 
sigmoid colon are bacteria derived externally via the rectum. Alternatively, 
environmental pressures (i.e. lower water and nutrient levels 2) could restrict 
outgrowth of dominant gastrointestinal species of the proximal colon, providing 
space for smaller communities of opportunistic species. The IgA response in the 
colon is antigen-specific rather than a general response to the presence of bacteria 
32. Thus, the overall increased number of unique species recognized by host IgA 
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antibodies in the sigmoid colon is fitting with the enhanced clonal expansion and 
mutation of plasma cells at this site.  
 
Together, our simultaneous analyses of microbiome and neighboring immune cells 
highlight the significance of environmental signals in shaping and maintaining 
regional adaptive immune cell composition and function in the intestine at steady-
state. Dysregulation of T helper cells 41 and plasma cells 42, has been implicated in 
susceptibility to inflammatory bowel disease. Observations of the linked 
compartmentalization of these immune cells and microbial species along the colon at 
steady-state may provide a platform for understanding the mechanisms underpinning 
the tropism of different intestinal diseases to specific regions of the gut, such as 
Crohn’s disease and ulcerative colitis.  
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Figures 
 
Figure 1: Variation in the microbiome from proximal to distal colon.  a) 
Workflow for 16S ribosomal sequencing of matching mucosal microbiomes and 
scRNA-seq profiling of immune cells from mesenteric lymph node (mLN), and lamina 
propria of cecum, transverse colon and sigmoid colon. b) Phylogenetic tree 
representing diversity and mean abundance of bacterial species in the cecum, 
transverse colon and sigmoid colon. Mean abundance was calculated as the 
percentage of operational taxonomic units (OTUs) for each species from total as 
determined by 16S rRNA sequencing and averaged for twelve donors (black scale). 
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Unassigned OTUs are shown as black branches. Bacteria groups of interest are 
highlighted. c) Relative abundances of OTUs at genus level of bacteria species in 
colon regions as in (b).  
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Figure 2: Profiling immune cells along the steady-state colon. a) UMAP 
illustration of pooled scRNA-seq data of immune cells of mLN, cecum, transverse 
colon and sigmoid colon from five donors colored by tissue of origin (left) and cell 
type annotation (right). b) Heatmap of mean expression of marker genes used to 
annotate cell types in (a). Point size shows the fraction of cells with nonzero 
expression. c) Relative percentages of CD4+ T subtypes within all CD4+ T cells for 
each tissue as in (a). d) Relative percentages of cell types within all non-CD4+ T 
immune cells for each tissue as in (a), with B lineage cells shown in the left panel 
and all other cell types in the right panel.  
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Figure 3: Dissemination of T helper cells in colon and region-determined 
transcriptional profiles. a) Correlation matrix of mean transcriptional profiles of TH1 
and TH17 cells from cecum, transverse colon, sigmoid colon and mLN (n=5 donors). 
b) Mean expression level of differentially expressed genes of pooled TH1 and TH17 
between cecum, transverse colon and sigmoid colon as in (a). Point size shows the 
fraction of cells with nonzero expression. c) UMAP projection of Smartseq2 profiled 
flow-sorted T cells annotated as TH1 and TH17 cells of the cecum, transverse colon 
and sigmoid colon (n=1 donor). Colored lines connect cells sharing the same CDR3 
sequence. d) Heatmap of numbers of members within clonal families in TH1/TH17 
subsets (left) and colon region (right) as in (c).  
 
Figure 4: Treg activation pathway from lymphoid to peripheral tissue. a) UMAP 
visualization of Treg subtypes in mLN (left) and pooled from cecum, transverse colon 
and sigmoid colon (right) (n=5 donors). b) Relative proportions of Treg subsets within 
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all Treg cells from mLN and colon tissue regions as in (a). Bars show mean proportion 
across all donors (circles). c) Density of Treg subclusters as in a across 
‘pseudospace’ (top) and expression kinetics of genes contributing to pseudospace 
smoothed into 100 bins (filtered by qval < 0.001 and expression in >15 cells). Top 
bar shows the most represented tissue within each bin. Various dynamically 
expressed immune-related molecules are annotated, with key genes colored red. 
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Figure 5: B cells are more abundant, clonal expanded and mutated in the 
sigmoid colon. a) Mean expression of key differentially expressed genes by IgA+ 
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plasma cells in cecum, transverse colon and sigmoid colon (n=5 donors). Point size 
shows the fraction of cells with nonzero expression. b) Proportion of CD27+ B cells of 
total B cells from cecum, transverse colon and sigmoid colon determined by flow 
cytometry (n=4 donors). Bar represents the mean and connected points represents 
values of each donor. Analysis is a two-tailed paired t test. c) UMAP visualization of 
B cells for which matched single-cell VDJ libraries were derived using 10x Genomics 
5’ scRNA-seq (n=2 donors) colored by cell type annotation (left), tissue (middle) and 
antibody isotype (right). Bar plot of antibody isotype frequencies per annotated cell 
type (far right). d) UMAP visualization of somatic hypermutation frequencies of IgH 
sequences as in (c). e) Quantitation of somatic hypermutation frequencies of IgH 
sequences from B cell types and gut regions as in (c). f) Estimated clonal 
abundances per donor for members of expanded B cell clones in B cell types and 
gut regions as in (c). g) Binary count of co-occurrence of expanded B cell clones 
identified by single-cell VDJ analysis shared across gut regions as in (c). h) Co-
occurrence of expanded B cell clones identified by bulk B cell receptor sequencing 
across gut regions (n=3 donors). Statistics in (e) and (f) are calculated with two-sided 
Wilcoxon signed-rank tests. Rows and columns in (g) and (H) are ordered by 
hierarchical clustering. * P <0.05; ** P <0.01; *** P <0.001; **** P <0.0001 
35 
 
Figure 6: Increasing number of microbiome species recognized by antibodies 
in the sigmoid colon. a) Experimental workflow for assessing Ig-opsonized colon 
bacterial species. b) Representative histogram of IgA1/2-bound Hoechst+ bacteria 
and summary plot of bound bacteria as a proportion of total bacteria (n=13 donors). 
Positive binding is set against an isotype control. c) Richness of bacteria species 
determined as the number of unique species and d) diversity of species identified 
from shotgun sequencing of Ig-opsonized bacteria from (b) (n=6 donors). P values 
were calculated using one-tailed paired t tests. * P <0.05 
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Human tissue was obtained from deceased transplant organ donors after ethical 
approval (reference 15/EE/0152, East of England Cambridge South Research Ethics 
Committee) and informed consent from the donor family. Fresh mucosal tissue from 
the cecum, transverse colon and sigmoid colon, and lymph nodes from the intestine 
mesentery, were excised within 60 minutes of circulatory arrest and colon tissue 
preserved in University of Wisconsin (UW) organ preservation solution (Belzer UW® 
Cold Storage Solution, Bridge to Life, USA) and mLN stored in saline at 4°C until 
processing. Tissue dissociation was conducted within 2 hours of tissue retrieval. 
Four individuals (287c, 296b, 403c and 411c) had received antibiotics in the two 
weeks prior to death (Supplementary Table 1). 
 
Tissue dissociation for FACS separation and MAC separation  
Tissue pieces from donors 290b, 298c, 302c, 364b and 411c were manually diced 
and transferred into 5 mM EDTA (Thermo Fisher Scientific)/1 mM DTT/10 mM 
HEPES (Thermo Fisher Scientific)/2% FBS in RPMI and incubated in a shaker (~200 
rpm) for 20 minutes at 37oC. Samples were briefly vortexed before the media 
renewed and incubation repeated. Tissue pieces were washed with 10 mM HEPES 
in PBS and transferred into 0.42 mg/ml Liberase DT (Roche)/0.125 KU DNase1 
(Sigma)/10 mM HEPES in RPMI and incubation for 30 minutes at 37oC. The 
digested samples were passed through a 40 µm strainer and washed through with 
FBS/PBS.  
 
Flow-sorting 
Cells from donor 290b, 298c and 302c were pelleted and resuspended in 40% 
Percoll (GE Healthcare). This was underlayed with 80% Percoll and centrifuged at 
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600g for 20 minutes with minimal acceleration and break. Cells at the interface were 
collected and washed with PBS. Cells were stained for fluorescent cytometry using 
Zombie Aqua Fixable Viability Dye (Biolegend, cat. 423101; diluted 1:200), CD45-
BV605 (clone HI30, Bioegend, cat. 304043; dilution 1:100), CD3-FITC (clone OKT3; 
Biolegend, cat. 317305; dilution 1:100), CD4-BV421 (clone SK3; Biolegend, cat. 
344631; dilution 1:100), CD8-PE-Cy7 (clone SK1, Biolegend, cat. 344711; dilution 
1:100), CD19-APC-Cy7 (clone HIB19, Biolegend, cat. 302217; dilution 1:100), IgD-
PE Dazzle (clone IA6-2, Biolegend, cat. 348207; dilution 1:100), CD27-BV711 (clone 
M-T271, Biolegend, cat. 356429; dilution 1:100), HLA-DR- BV785 (clone L243, 
Biolegend, cat. 307641; dilution 1:100), CD14-APC (clone 63D3, Biolegend, cat. 
367117; dilution 1:100) and CD11c-PE (clone 3.9; eBioscience, cat. 12-0116-42; 
dilution 1:100). Non-CD4+ T immune cells were sorted as live singlet CD45+, CD3- 
and CD4–. CD4+ T cells were sorted as live singlet CD45+, CD3+ and CD4+. Each 
faction was manually counted using 0.4% Trypan Blue (gibco) and a 
haemocytometer and diluted to 500 cells/µl in PBS. Sorting was carried out on a BD 
FACS ARIA Fusion. Analysis of flow-sorting data was conducted with FlowJo 
Software package (version 10.4).  
 
MACS cell enrichment 
Cells from donor 411c were pelleted for 5 minutes at 300g and resuspended in 80 µl 
of ice-cold MACS buffer (0.5% BSA (Sigma-Aldrich Co. Ltd), 2 mM EDTA 
(ThermoFisher) in DPBS (Gibco)) and 20 µl of CD45 Microbeads (Miltenyi Biotech). 
Cells were incubated for 15 minutes at 4oC before being washed with 2 ml of MACS 
buffer and centrifuged as above. Cells were resuspended in 500 µl of MACS buffer 
and passed through a pre-wetted MS column on QuadroMACS magnetic cell 
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separator (Miltenyi). The column was washed 4 times with 500 µl of MACS buffer, 
allowing the full volume of each wash to pass through the column before the next 
wash. The column was removed from the magnet and the cells eluted with force with 
1 ml of MACS buffer into a 15 ml tube. Cells were pelleted as above and cell number 
and viability were determined using a NucleoCounter NC-200 and Via1-Cassette 
(ChemoMetec). Cells were resuspended at 500 cells/µl in 0.04% BSA in PBS. 
 
Tissue dissociation for Ficoll separation 
Tissues from donor 390c were manually diced and <5.0 grams was added per 
Miltenyi C tube with 5mL tissue dissociation media (1x Liberase TL (0.13 
U/mL/DNase; Roche) and Benzonase nuclease (10 U/mL; Merck) in 1% FCS and 20 
mM HEPES in PBS (Lonza). Samples were dissociated with GentleMACS Octo for 
30 minutes homogenizing/37oC cycle. Enzymatic digestion was stopped with the 
addition of 2 mM EDTA in tissue dissociation media. Digested samples were then 
passed through a 70 µM smart strainer (Miltenyi) before being washed with PBS and 
pelleted at 500g for 10 minutes. Cells were resuspended in PBS, layered onto 
FicollPaque Plus (GE Healthcare) and spun at RT 400g for 25 minutes. Mononuclear 
cells were retrieved from Ficoll layer and washed with PBS. Cells were filtered 
through 0.2 µM filter (FLowmi cell strainers, BelArt). Cells were manually counted 
using a hemocytometer and diluted to a concentration of 1000 cells/µl in 0.04% BSA 
in PBS.  
 
10x Genomics Chromium GEX library preparation and sequencing 
Cells were loaded according to the manufacturer’s protocol for Chromium single cell 
3’ kit (version 2) or 5’ gene expression (version 2) in order to attain between 2000-
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5000 cells/well. Library preparation was carried out according to the manufacturer’s 
protocol. For samples from donors 290b, 298c and 302c, eight 10x Genomics 
Chromium 3’ libraries were pooled sequenced on eight lanes of an Illumina Hiseq 
4000. For samples from donors 390c and 417c, sixteen 10x Genomics Chromium 5’ 
libraries were pooled and sequenced on 2 lanes of a S2 flowcell of Illumina Novaseq 
with 50 bp paired end reads.  
 
10x Genomics Chromium VDJ library preparation and sequencing 
10x Genomics VDJ libraries were generated from the 5’ 10x Genomics Chromium 
cDNA libraries as detailed in the manufacturer's protocol. BCR libraries for each 
sample were pooled and sequenced on a single lane of Illumina HiSeq 4000 with 
150 bp paired end reads. 
 
Plate-based scRNA-seq 
Plate-based scRNA-seq was performed with the NEBNext Single Cell/Low Input 
RNA Library Prep Kit for Illumina (New England Biolabs Inc, E6420L). Cells from 
donor 364b were snap frozen in 10% DMSO in 90% BSA. Cells were thawed rapidly 
in a 37oC water bath and diluted slowly with pre-warmed 2% FBS in D-PBS. Cells 
were pelleted for 5 minutes at 300g and washed with 500 µl of DPBS and pelleted as 
before. Cells were resuspended in 200 µl of CD25-PE (clone M-A251, Biolegend, 
cat. 356102; diluted 1:200), CD127-FITC (clone eBioRDR5, eBioscience, cat. 11-
1278-42; diluted 1:200), CD4-BV421 (clone SK3, Biolegend, cat. 344632; diluted 
1:200) and TCRα/β-APC (clone 1p26, Biolegend, cat. 306718; diluted 1:200) and 
Zombie Aqua Fixable Viability Dye (diluted 1:400) and incubated for 30 minutes in 
the dark at room temperature. Cells were washed twice with 500 µl of 2% FBS in D-
40 
PBS before being filtered through a 100 µM filter. Single, live, TCRβ+ cells were 
FACS sorted into a pre-prepared 384-well plate (Eppendorf, Cat. No. 0030128508) 
containing 2 µl of 1X NEBNext Cell Lysis Buffer. FACS sorting was performed with a 
BD Influx sorter with the indexing setting enabled. Plates were sealed and spun at 
100g for 1 minute then immediately frozen on dry ice and stored at -80°C.  
 
cDNA generation was then performed in an automated manner on the Agilent Bravo 
NGS workstation (Agilent Technologies). Briefly, 1.6 µl of Single Cell RT Primer Mix 
was added to each well and annealed on a PCR machine (MJ Research Peltier 
Thermal Cycler) at 70°C for 5 minutes. 4.4 µl of Reverse Transcription (RT) mix was 
added to the mixture and further incubated at 42°C for 90 minutes followed by 70°C 
for 10 minutes to generate cDNA. 22 µl of cDNA amplification mix containing 
NEBNext Single Cell cDNA PCR MasterMix and PCR primer was mixed with the 
cDNA, sealed and spun at 100g for 1 minute. cDNA amplification was then 
performed on a PCR machine (MJ Research Peltier Thermal Cycler) with 98°C 45 s, 
20 cycles of [98°C 10 s, 62°C 15 s, 72°C 3 mins], 72°C 5 mins. The 384-well plate 
containing the amplified cDNA was purified with an AMPure XP workflow (Beckman 
Coulter, Cat No. A63880) and quantified with the Accuclear Ultra High Sensitivity 
dsDNA kit (Biotium, Cat. No. 31028). ~10 ng of cDNA was stamped into a fresh 384-
well plate (Eppendorf, Cat. No. 0030128508) for sequencing library preparation. 
 
Sequencing libraries were then generated on the Agilent Bravo NGS workstation 
(Agilent Technologies). Purified cDNA was fragmented by the addition of 0.8 µl of 
NEBNext Ultra II FS Enzyme Mix and 2.8 µl of NEBNext Ultra II FS Reaction buffer 
to each well and incubated on a PCR machine (MJ Research Peltier Thermal Cycler) 
41 
for 72°C at 15 minutes and 65°C for 30 minutes. A ligation mixture was then 
prepared containing NEBNext Ultra II Ligation Master Mix, NEBNext Ligation 
Enhancer and 100 µM Illumina compatible adapters (Integrated DNA Technologies) 
and 13.4 µl added to each well of the 384-well plate. The ligation reaction was 
incubated on the Agilent workstation at 20°C for 15 minutes and then purified and 
size selected with an AMPure XP workflow (Beckman Coulter, Cat No. A63880). 20 
µl of KAPA HiFi HS Ready Mix (Kapa Biosystems, Cat. No. 07958927001) was then 
added to a pre-prepared 384-well plate (Eppendorf, Cat. No. 0030128508) 
containing 100 µM i5 and i7 indexing primer mix (50 µM each) (Integrated DNA 
Technologies). The indexing primers pairs were unique to allow multiplexing of up to 
384 single cells in one sequencing pool. The plate containing the PCR Master Mix 
and indexing primers was stamped onto the adapter ligated purified cDNA, sealed 
and spun at 100g for 1 minute. Amplification was performed on a PCR machine (MJ 
Research Peltier Thermal Cycler) with 95°C for 5 minutes, 8 cycles of [98°C 30 
seconds, 65°C 30 seconds, 72°C 1 minute], 72°C 5 minutes. The PCR products 
were pooled in equal volume on the Microlab STAR automated liquid handler 
(Hamilton Robotics) and the pool purified and size selected with an AMPure XP 
workflow (Beckman Coulter, Cat No. A63880). The purified pool was quantified on 
an Agilent Bioanalyser (Agilent Technologies) and sequenced on one lane of an 
Illumina HiSeq 4000 instrument. 
 
Single-cell RNA sequencing data alignment 
10x Genomics gene expression raw sequencing data was processed using 
CellRanger software version 3.0.2 and 10X human genome GRCh38-3.0.0 as the 
reference. 10x Genomics VDJ immunoglobulin heavy and light chain were 
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processed using cellranger vdj (version 3.1.0) and the reference cellranger-vdj-
GRCh38-alts-ensembl-3.1.0 with default settings. NEB sequencing data was 
processed using STAR 2.5.1b into HTSeq (version 0.11.2) and mapped to 10X 
human genome GRCh38-1.2.0.  
 
Single-cell RNA sequencing quality control 
Single cell read counts from all samples were pooled and filtered considering 
number of UMIs - keeping genes expressed in minimum of 3 cells, keeping cells 
where genes detected are in a range 700-6000. Non-immune cells were excluded 
from the final analysis based on the absence of PTPRC and presence of markers 
such as EPCAM (epithelial cells) and COL1A1 (fibroblasts). 
 
Cell type annotation 
Cells were clustered using Scanpy (version 1.4) processing pipeline 43. In short, the 
counts were normalized to 10,000 reads per cell (sc.pp.normalise_per_cell) and log 
transformed (sc.pp.log1p) to be comparable amongst the cells. The number of UMIs 
and percentage of mitochondrial genes were regressed out (sc.pp.regress_out) and 
genes were scaled (sc.pp.scale) to unit variance. The normalized counts were used 
to detect highly variable genes (sc.pp.highly_variable_genes). Batch correction 
between the donors was performed using bbknn (version 1.3.6) 44 on 50 PCs and 
trim parameter set to 100. Clusters were then identified using Leiden graph-based 
clustering (resolution set to 1). Cell identity was assigned using known markers 
shown in Figure 2b and the top differentially expressed genes identified using 
Wilcoxon rank-sum test (sc.tl.rank_genes_groups function, Supplementary Table 4). 
CD4 T cells, myeloid cells, B cells were subclustered for identification of subsets 
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within each cluster. Treg cells annotated above were further subclustered using the 
“FindClusters” and “RunUMAP” functions from Seurat (version 3.0.1)45 (Figure 4).  
The number of PCs used for Treg cell clustering were estimated by the elbow of a 
PCA screen plot, in combination to manual exploration of the top genes from each 
PC. Clustering of mLN Treg cells was performed using 1-14 PCs and resolution of 0.3 
and colonic Treg cells with 1-11 PCs and resolution of 0.3.  
 
‘Pseudospace’ analysis 
‘Pseudospace’ analysis of Treg cells was performed using Monocle 2.2.0 46. Data was 
log normalized and cell ordered based on DDRTree reduction on highly variable 
genes with donor effect regression. The heatmap in Figure 4c was generated using 
the “plot_pseudotime_heatmap” function in Monocle 2.2.0 46. Genes contributing to 
‘pseudospace’ were first filtered for exclusion of mitochondria and immunoglobulin 
genes, expression in at least 15 cells and qval < 0.001. Gene expression was 
smoothed into 100 bins along pseudospace using a natural spline with 3 degrees of 
freedom. Matching column annotation for each bin was determined as the most 
prevalent tissue region origin of the cells within that bin. Genes were grouped into 2 
clusters and ordered by hierarchical clustering. Cells were ordered through 
pseudotime. 
 
Sampling of microbiome 
Swabs were taken immediate of the mucosal surface of excised tissue using MWE 
Transwab Cary Blair (catalogue number: MW168). Swabs were maintained at 4oC. 
Working in a biosafety cabinet, swabs were washed in 500 µl of anaerobic PBS and 
44 
mixed with anaerobic 50% glycerol before being snap frozen on dry ice and stored at 
-80oC until use.  
 
Microbiota profiling and sequencing 
The microbiota vials were defrosted on ice. Approximately 100 µl of each was 
transferred into new Eppendorf tubes. DNA was extracted from microbiome samples 
using the MP Biomedical FastDNA SPIN Kit for soil (catalogue number 116560200). 
16S rRNA gene amplicon libraries were made by PCR amplification of variable 
regions 1 and 2 of the 16S rRNA gene using the Q5 High-Fidelity Polymerase Kit 
supplied by New England Biolabs as described in 47. Primers 27F 
AATGATACGGCGACCACCGAGATCTACAC (first part, Illumina adaptor) 
TATGGTAATT (second part, forward primer pad) CC (third part, forward primer 
linker) AGMGTTYGATYMTGGCTCAG (fourth part, forward primer) and 338R 
CAAGCAGAAGACGGCATACGAGAT (first part, reverse complement of 3′ Illumina 
adaptor) ACGAGACTGATT (second part, golay barcode) AGTCAGTCAG (third part, 
reverse primer pad) AA (fourth part, reverse primer linker) 
GCTGCCTCCCGTAGGAGT (fifth part, reverse primer) were used. Four PCR 
amplification reactions per sample were carried out; products were pooled and 
combined in equimolar amounts for sequencing using the Illumina MiSeq platform, 
generating 150 bp reads. Analysis of partial 16S rRNA sequences was carried out 
using SILVA v132 and mothur MiSeq SOP v1.42.3 48. The 16S rRNA gene 
alignments were used to determine a maximum likelihood phylogeny using FastTree 
(version 2.1.10) 49. Phylogenetic trees were visualized and edited using iTOL 
(version 5) 50. 
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T cell clonal sharing analysis 
T cell receptor sequences generated using the Smartseq2 scRNA-seq protocol were 
reconstructed using the TraCeR software as previously described 51. 
  
Bulk B cell receptor sequencing  
Small portions of samples were taken from excised tissues and snap frozen in 1ml of 
RNAlater (Ambion). RNA extracted from tissue using the QIAshreddar and QIAGEN 
Mini Kit (50). RNA concentration was measured using a Bioanalyzer. B Cell 
Receptor (BCR) heavy chain sequences of all B lineage subsets present in the 
tissue were amplified as previously described 52. Briefly, RNA was reverse 
transcribed using a barcoded reverse primer set capturing all antibody (sub)classes. 
Targeted heavy-chain amplification was performed with a multiplex set of IGHV gene 
primers to FR1 and a universal reverse primer using HiFi qPCR KAPA Biosystems. 
After adapter filtering and trimming, BCR sequences were assembled and aligned 
using MiXCR (version 3.0.1) 53. It is worth noting that detected BCR sequences are 
biased towards those included in the reference database and while there is a 
continuous discovery of novel germline alleles, no database is currently a complete 
reflection of the human IGH locus diversity. Only in-frame and IGH sequences with 
at least 3 read counts were kept for the analysis. To calculate the CDR3 nucleotide 
shared repertoire, the tcR package (version 2.2.1) was used 54. 
 
10x Genomics single-cell VDJ data processing, quality control and annotation 
Poor quality VDJ contigs that either did not map to immunoglobulin chains or were 
assigned incomplete by cellranger vdj were discarded. For additional processing, all 
IgH sequence contigs per donor were combined together. We further filtered IgH 
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contigs as to whether they had sufficient coverage of constant regions to ensure 
accurate isotype assignment between closely related subclasses using 
MaskPrimers.py (pRESTO version 0.5.10) 55. IgH sequences were then further 
annotated using IgBlast 56 and reassigned isotype classes using AssignGenes.py 
(pRESTO) prior to correction of ambiguous V gene assignments using TIgGER 
(version .03.1) 57. Clonally-related IgH sequences were identified using 
DefineClones.py (ChangeO version 0.4.5) 57 with a nearest neighbor distance 
threshold of 0.2, as determined by visual inspection of the output of distToNearest 
(Shazam version 0.1.11) 57. CreateGermlines.py (ChangeO version 0.4.5) was then 
used to infer germline sequences for each clonal family and observedMutations 
(Shazam version 0.1.11) was used to calculate somatic hypermutation frequencies 
for each IgH contig. Estimated clonal abundances and IgH diversity analyses within 
each donor were performed using estimateAbundance, rarefyDiversity and 
testDiversity of Alakazam (version 0.2.11) 57 with a bootstrap number of 500. Finally, 
the number of quality filtered and annotated IgH, IgK or IgL chains were determined 
per unique cell barcode. If more than one contig per chain was identified, metadata 
for that cell was ascribed as “Multi”. The subsequent metadata table was then 
integrated with the single-cell RNA-seq gene expression objects for annotation of 
IgH contigs with B cell types and downstream analysis. Co-occurrence of expanded 
clone members between tissues and/or cell types was reported as a binary event for 
each clone that contained a member within two different tissues and/or cell types. 
 
Quantifying IgA binding of bacteria 
Microbiome frozen in 50% glycerol were defrosted on ice before being washed in 
PBS and pelleted for 3 minutes at 8,000 rpm. Bacteria were then stained on ice for 
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30 minutes with IgG-PE (Biolegend, clone HP6017, cat. 409304; dilution 1:100), 
IgA1/2 biotin (BD, clone G20-359, cat. 555884; dilution 1:50), followed by 20 minutes 
with streptavidin-APC (Biolegend, cat. 405207; dilution 1:100). For isotype controls, 
mouse IgG1 κ Isotype- Biotin (BD, cat. 550615; dilution 1:50) or mouse IgG2a, κ 
Isotype- PE (Biolegend, cat. 400212; dilution 1:100) were used. The bacteria were 
washed before and after DNA was stained with Hoechst33342 (Sigma-Aldrich). The 
stained bacteria were sorted as Hoechst+ and IgG+IgA+ or IgG–IgA+ into PBS using 
the BD Influx and then stored at -80oC until DNA extraction. 
 
Genomic DNA Extraction for shotgun sequencing of IgA-bound bacteria 
Bacteria in PBS was defrosted on ice before being pelleted at 3900 rpm for 5 
minutes at 4oC. The supernatant was removed and the pellet resuspended in 2 ml of 
25% sucrose in TE Buffer (10mM Tris pH8 and 1mM EDTA pH8). 50 µl of 100 mg/ml 
lysozyme in 0.25M Tris was added and incubated at 37oC for 1 hour. 100ul of 
Proteinase K (18 mg/ml),15 µl of RNAase A (20 mg/ml), 400 µl of 0.5 M EDTA (pH 
8), and 250 µl of 10% Sarkosyl were then added. This was left on ice for 2 hours and 
then incubated at 50oC. The DNA was then isolated by running through a gel, 
samples quantitated by qbit and pooled. Pooled DNA was sequenced on the Illumina 
Hiseq2500 platform. Inverse Simpson (diversity) and chao (richness) of IgA-
opsonized bacteria was determined by using R package “microbiome”. 
 
Statistical analysis 
Sample sizes for each experimental group and statistical tests used are included in 
the relevant figure legends. Measurements were taken from distinct donors in all 
experiments.  
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Reporting summary 
Further information on research design is available in the Nature Research 
Reporting Summary linked to this paper. 
 
Data availability 
Raw sequencing data files are available at ArrayExpress (accession numbers: E-
MTAB-8007, E-MTAB-8474, E-MTAB-8476, E-MTAB-8484 & E-MTAB-8486). 
Sequencing data for the microbiome are available at MGnify (ERA numbers are 
listed in Supplementary Table 6). Processed single-cell RNA sequencing data is 
available for online visualization and download at gutcellatlas.org. 
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